Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa in Dengue Haemorrhagic Fever
NCT01601613Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2001
- Primary completion
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of coagulation factor VIIa in dengue hemorrhagic fever (DHF), sponsored by Novo Nordisk. Started Jul 2001; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
dengue hemorrhagic fever (DHF)
Beyond the preview
Go deeper on NCT01601613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601613.